Walgreens Effervescent Cold Relief Plus Tablet, Effervescent
NDC Package 0363-0875-36
Package Information
Walgreens Effervescent Cold Relief Plus (aspirin, chlorpheniramine maleate, phenylephrine bitartrate) tablets is ■ do not use more than directed (see overdose warning)■ adults and children 12 years and over: take 2 tablets completely dissolved in 4 oz of water every 4 hours■ do not take more than 8 tablets in 24 hours■ children under 12 years: ask a doctor. This formulation utilizes a tablet, effervescent delivery system. Marketed by Walgreens, this product is identified by NDC 0363-0875 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1536840 - aspirin 325 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
- RxCUI: 1536840 - ASA 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0363 - Walgreens
- 0363-0875 - Walgreens Effervescent Cold Relief Plus
- 0363-0875-36 - 18 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
- 0363-0875 - Walgreens Effervescent Cold Relief Plus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0363-0875). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0363-0875-36 identifies a specific commercial package of 18 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Walgreens Effervescent Cold Relief Plus, a human over the counter drug labeled by Walgreens. This tablet, effervescent is formulated for oral use and contains aspirin; chlorpheniramine maleate; phenylephrine bitartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens on October 24, 2014. The current certification is valid through December 31, 2026.
How is this Walgreens product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363087536. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.